Social Media Ideas for Cdmo Pharmaceutical

How Companies Evaluate CDMO Pharmaceutical Partners for Long-Term Success

Choosing a contract manufacturing partner is one of the most consequential decisions a […]

5 Indian CDMO Stocks Benefiting from the Global Pharma Outsourcing Boom

Synopsis: Global pharmaceutical companies are rapidly diversifying their manufacturing supply chains as geopolitical tensions, regulatory changes and the proposed U.S. BIOSECURE Ac...

Shilpa Commissions Integrated ADC Drug Substance GMP Manufacturing Facility

The manufacturing of highly potent compounds has been a core pillar of Shilpa’s identity, and this ADC drug substance facility adds a new sophisticated dimension to the Shilpa grou...

<![CDATA[Additive Manufacturing's Application in Pharma and Biotech]]>

Oligonucleotide Therapeutic Industry Readies Itself to Move to the Next Phase

As synthetic oligonucleotide therapeutics become validated and feasible for commercial production, manufacturers are being urged to become familiar with the Chemistry, Manufacturin...

CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity

Acquisition strengthens U.S. peptide manufacturing capabilities and broadens global expertise in complex peptide APIs

Managing complexity across biopharma modalities

SK pharmteco CEO Joerg Ahlgrimm discusses complexity, global pressure and drug development speed.

Caidya and Simbec-Orion unite in global CRO combo

Contract research organizations (CROs) Caidya and Simbec-Orion have united to create a new platform aimed at helping drug development programs accelerate and scale.

WuXi Biologics' Suzhou Biosafety Testing Center Received Fourth EMA GMP Certification, Enabling 19 Commercial Products f...

SUZHOU, China, June 18, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its Bi...

Viral vector production: How CDMOs influence late-stage development success

Explore how viral vector CDMOs improve late-stage cell and gene therapy success by reducing risk, variability, and complexity. The post Viral vector production: How CDMOs influence...

WACKER offers Contract Research Services (CRS) for nucleic acid-based pharmaceuticals

- - • The new CRS expand WACKER's offering for biotech and biopharmaceutical customers worldwide and complement Wacker Biotech's CDMO services. - - • The Munich team at the...

End-to-end: Curia drives supply and scale for steroid and hormonal therapies

Explore how Curia tackles steroid manufacturing complexity, from early development to scaled, end-to-end commercial supply. The post End-to-end: Curia drives supply and scale for s...

Akums Reports Q4 FY26 and Full Year FY26 Results with Healthy Top Line and Strong EBITDA Growth; Board Recommends Divide...

NewsVoirNew Delhi [India], May 15: Akums Drugs & Pharmaceuticals Ltd., India's largest Contract Development and Manufacturing Organisation (CDMO), announced its financial resul...

Akums Reports Q4 FY26 and Full Year FY26 Results with Healthy Top Line and Strong EBITDA Growth; Board Recommends Divide...

NewsVoirNew Delhi [India], May 15: Akums Drugs & Pharmaceuticals Ltd., India's largest Contract Development and Manufacturing Organisation (CDMO), announced its financial resul...

<![CDATA[FDA Sends CRL to Cingulate for CTx-1301]]>

For biopharma manufacturing at speed and scale, the future is flexible

Biopharma development has long trended toward specialized and personalized therapies such as cell and gene therapies, antibody-drug conjugates, and monoclonal antibodies (mAbs), am...

Made Scientific, Pluristyx launch development and manufacturing partnership

Made Scientific Inc., a clinical- and commercial-stage cell therapy contract development and manufacturing organization (CDMO), and Pluristyx, a provider of cell (iPSC) platform te...

Peptistar Began Operation of the Asahi Kasei FO-MD System at Manufacturing Scale

FO utilizes an osmotic pressure difference across a membrane to remove water from liquids, achieving highly concentrated API solutions under mild conditions. MD leverages a vapor p...

<![CDATA[Insilico Medicine and CMS Enter $177 Million AI-Powered Drug Discovery Collaboration]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Sends Complete Response Letter for Cingulate's CTx-1301]]>

<![CDATA[How 3D Printing Speeds Up Drug Production]]>

Major Biopharmaceutical Company Files First-in-Human Trial Supported by PAK BioSolutions GMP Purification System

A major biopharmaceutical company has filed a First-in-Human (FIH) clinical trial application with drug product manufactured using the PAK BioSolutions system. The milestone demons...

<![CDATA[Pharma M&A Roundup: Chemomab Therapeutics Enters Merger Agreement with Scipher Medicine, Teva and Polpha...

Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improve

Laurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The company is investing ₹3,000 crore in exp...